Sarah K. Baird
- Co-authors
- Ulf T. BrunkTino KurzWei LiXi YuanIain A. McNeishSteven P. GiesegMark B. HamptonNicholas R. Lemoine
- Topics
- Peptidase Inhibition and Analysis (4 papers)Protease and Inhibitor Mechanisms (4 papers)Virus-based gene therapy research (3 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- New ZealandUnited KingdomSweden
In The Last Decade
Sarah K. Baird
28 papers receiving 828 citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 335
- Oncology 250
- Surgery 129
- Cancer Research 129
- Genetics 122
Countries citing papers authored by Sarah K. Baird
This map shows the geographic impact of Sarah K. Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah K. Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah K. Baird more than expected).
Fields of papers citing papers by Sarah K. Baird
This network shows the impact of papers produced by Sarah K. Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah K. Baird. The network helps show where Sarah K. Baird may publish in the future.
Co-authorship network of co-authors of Sarah K. Baird
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah K. Baird. A scholar is included among the top collaborators of Sarah K. Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah K. Baird. Sarah K. Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 7 | |
| 3 | 17 | |
| 4 | 12 | |
| 5 | 14 | |
| 6 | 64 | |
| 7 | 90 | |
| 8 | 24 | |
| 9 | 4 | |
| 10 | 74 | |
| 11 | 48 | |
| 12 | 10 | |
| 13 | 22 | |
| 14 | 64 | |
| 15 | 23 | |
| 16 | 73 | |
| 17 | 36 | |
| 18 | 55 | |
| 19 | 18 | |
| 20 | 0 |
About Sarah K. Baird
Sarah K. Baird is a scholar working on Clinical Biochemistry, Genetics and Cancer Research, having authored 29 papers that have together received 850 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (250 citations), Cancer Research (129 citations) and Genetics (89 citations). Sarah K. Baird has collaborated with scholars based in New Zealand, United Kingdom and Sweden. Frequent co-authors include Ulf T. Brunk, Tino Kurz, Wei Li, Xi Yuan, Iain A. McNeish, Steven P. Gieseg, Mark B. Hampton, Nicholas R. Lemoine, Joeri L. Aerts and Michelle Lockley. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.